Print

PREVAIL Study: A Genetic Education and Genetic Testing Study for African American Men with Prostate Cancer or with a Strong Family History of Cancer

https://www.facingourrisk.org/research-clinical-trials/study/448 /prevail-study-a-genetic-education-and-genetic-testing-study-for-african-american-men-with-prostate-cancer-or-with-a-strong-family-history-of-cancer

Prevention
Genetic testing for African American men with prostate cancer or cancer in the family

Study Contact Information:

Study Coordinators:
Laura Gross [email protected]
Liz Perrotti [email protected] (203) 737-5250


About the Study

The purpose of the PREVAIL study is to evaluate a genetic education video that will deliver information about genetic testing for African American men in a relatable way and increase access to genetic testing. African American men with prostate cancer or with a strong family history of cancer may be eligible for the study. Participants can choose to view the video or see a genetic counselor before making a decision for genetic testing. The entire study can be completed remotely for participants from specific states. 

The study includes the option of having free cancer genetic testing for participants who qualify. 

What the Study Involves

Your participation in the study will involve:

To get started with determining your eligibility for the study, please scan the QR code or visit https://redcap.link/PREVAIL

 

 

 

Lead Researcher: 

Veda Giri, MD
Yale Cancer Center


This Study is Open To:

African American men with prostate cancer, or with a strong family history of cancer, who live in the following states may be eligible to participate:

This Study is Not Open To:

Men who do not live in any of the above states or who have had prior genetic counseling or genetic testing for inherited cancer risk are not eligible to participate.


About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.